616 related articles for article (PubMed ID: 30895242)
1. The use of long-acting reversible contraceptives in Latin America and the Caribbean: current landscape and recommendations.
Bahamondes L; Villarroel C; Frías Guzmán N; Oizerovich S; Velázquez-Ramírez N; Monteiro I
Hum Reprod Open; 2018; 2018(1):hox030. PubMed ID: 30895242
[TBL] [Abstract][Full Text] [Related]
2. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
3. Contraceptive sales in the setting of the Zika virus epidemic.
Bahamondes L; Ali M; Monteiro I; Fernandes A
Hum Reprod; 2017 Jan; 32(1):88-93. PubMed ID: 27932442
[TBL] [Abstract][Full Text] [Related]
4. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
5. Magnitude and factors for method discontinuation and switching among long acting reversible contraceptive users in health facilities of Southern Ethiopia.
Bereku T; Habtu Y; Abreham B; Ayele M; Eliso M
Reprod Health; 2022 Feb; 19(1):47. PubMed ID: 35183214
[TBL] [Abstract][Full Text] [Related]
6. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
7. Access to sexual and reproductive health services for women living with HIV in Latin America and the Caribbean: systematic review of the literature.
Gómez-Suárez M; Mello MB; Gonzalez MA; Ghidinelli M; Pérez F
J Int AIDS Soc; 2019 Apr; 22(4):e25273. PubMed ID: 30958638
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries.
Ponce de Leon RG; Ewerling F; Serruya SJ; Silveira MF; Sanhueza A; Moazzam A; Becerra-Posada F; Coll CVN; Hellwig F; Victora CG; Barros AJD
Lancet Glob Health; 2019 Feb; 7(2):e227-e235. PubMed ID: 30683240
[TBL] [Abstract][Full Text] [Related]
9. Training of healthcare providers and use of long-acting reversible contraception in low- and middle-income countries: A systematic review.
Stokholm Baekgaard R; Gjaerevold Damhaugh E; Mrema D; Rasch V; Khan K; Linde DS
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):619-628. PubMed ID: 33594675
[TBL] [Abstract][Full Text] [Related]
10. Projections and opinions from 100 experts in long-acting reversible contraception.
Foster DG; Barar R; Gould H; Gomez I; Nguyen D; Biggs MA
Contraception; 2015 Dec; 92(6):543-52. PubMed ID: 26515195
[TBL] [Abstract][Full Text] [Related]
11. Contraceptive prevalence, reproductive health and our common future.
Diczfalusy E
Contraception; 1991 Mar; 43(3):201-27. PubMed ID: 2036793
[TBL] [Abstract][Full Text] [Related]
12. Would you offer contraception to a 14-year-old girl? Perspectives of health students and professionals in Dar es Salaam, Tanzania.
Mwakawanga DL; Mkonyi E; Mushy SE; Trent M; Bonilla Z; Massae AF; Lukumay GG; Mgopa LR; Mohammed I; Wadley J; Ross MW; Leshabari S; Rosser BRS
Reprod Health; 2021 Dec; 18(1):245. PubMed ID: 34895267
[TBL] [Abstract][Full Text] [Related]
13. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
15. Abortion policy and women's health in developing countries.
Dixon-Mueller R
Int J Health Serv; 1990; 20(2):297-314. PubMed ID: 2332264
[TBL] [Abstract][Full Text] [Related]
16. Long-acting reversible contraceptives use among adolescent girls and young women in high fertility countries in sub-Saharan Africa.
Sambah F; Aboagye RG; Seidu AA; Tengan CL; Salihu T; Ahinkorah BO
Reprod Health; 2022 Nov; 19(1):209. PubMed ID: 36384976
[TBL] [Abstract][Full Text] [Related]
17. Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.
Garrett CC; Keogh LA; Kavanagh A; Tomnay J; Hocking JS
BMC Womens Health; 2015 Sep; 15():72. PubMed ID: 26359250
[TBL] [Abstract][Full Text] [Related]
18. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
19. Time to second abortion or continued pregnancy following a first abortion: a retrospective cohort study.
Rose SB; Stanley J; Lawton BA
Hum Reprod; 2015 Jan; 30(1):214-21. PubMed ID: 25355588
[TBL] [Abstract][Full Text] [Related]
20. Timing of contraceptive initiation and association with future sexual and reproductive outcomes.
True K; Bajos N; Bohet A; Moreau C
Hum Reprod; 2014 Aug; 29(8):1651-8. PubMed ID: 24916436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
